These outcomes, together with a previous report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the principle of targeting ACKR3 as a novel approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Issues.Healthy joints enable us to move with ease.